XELJANZ XR (TOFACITINIB CITRATE) — FDA Approval NDA208246 (PFIZER)
XELJANZ XR (TOFACITINIB CITRATE) — FDA Approval NDA208246 (PFIZER) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: XELJANZ XR; Active ingredients: TOFACITINIB CITRATE; Application number: NDA208246.
| Brand name | XELJANZ XR |
|---|---|
| Active ingredients | TOFACITINIB CITRATE |
| Application number | NDA208246 |
| Sponsor | PFIZER |
| Dosage form | TABLET, EXTENDED RELEASE |
| Route | ORAL |
| Marketing status | Prescription |
| Products in application | 2 |
| First approval date | 20160223 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →